Clinical Trial Update: A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma [NA]

View source ↗

Summary

A two-arm, multicenter, non-randomized study evaluating Yttrium-90 selective internal radiation therapy and hepatic arterial infusion chemotherapy for potential…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Hepatic Arterial Infusion Chemotherapy
• Yttrium-90 (Selective Internal Radiation Therapy)

Snippet

Sponsor: Li Qiang | Conditions: Hepatocellular Carcinoma (HCC) | NA | Status: RECRUITING